(Q35562998)

8 August 2017

0 references

The potential epidemiological impact of a genital herpes vaccine for women (English)

1 reference

8 August 2017

1 reference

1 reference

3

Slaoui M

1 reference

8 August 2017

Garnett GP

1

1 reference

8 August 2017

Dubin G

series ordinal

2

1 reference

8 August 2017

Darcis T

series ordinal

4

1 reference

8 August 2017

publication date

1 February 2004

1 reference

Sexually Transmitted Infections

8 August 2017

published in

1 reference

8 August 2017

volume

80

1 reference

8 August 2017

issue

1

1 reference

8 August 2017

page(s)

24-29

1 reference

Mathematical models of the transmission and control of sexually transmitted diseases

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Sex acts, sex partners, and sex budgets: implications for risk factor analysis and estimation of HIV transmission probabilities

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Risk Factors for the Sexual Transmission of Genital Herpes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Measuring the risk of HIV transmission

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Herpes simplex virus type 2 in the United States, 1976 to 1994.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758372

Estimability and Interpretation of Vaccine Efficacy Using Frailty Mixing Models

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14755031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14755031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/STI.2002.003848

1 reference

8 August 2017

1 reference

8 August 2017

1 reference